AzTrials
AzTrials

Healthy Aging4MIITNCT05207501

Effects of Different Moderate-intensity Exercise Methods on Health in the Elderly

A study testing Exercise in people with Healthy Aging, run by University of Lausanne at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Aging is linked to a higher risk of cardiovascular disease. Physical exercise is recognized as an excellent strategy to prevent cardiovascular diseases and cognitive aspects, generating healthier elderly people. The beneficial effects of physical training seem to be greater when performed: In hypoxic conditions (i.e. Read more about this study

Who is it for?
Ages 65 to 75 yearsHealthy volunteers can take part
Conditions the study is for
Healthy Aging
What is being tested?
Exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteSwitzerland
Study dates
1 Sep 2022to 30 Mar 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 to 75 years
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • to be aged between 65 and 75 years old
  • not involved in regular physical activities for at least 6 months (i.e., doing no physical exercise over twice per week);
  • free of injuries as well as cardiovascular and respiratory disorders or central nervous system disease or receiving β-blocker medication;
  • not using dietary supplements, smoking or drugs which interfere with the measurements;
  • not using creatine supplementation, anabolic steroids, drugs, or medication with potential effects on physical performance;
  • to have body index mass between 20 and 30 kg/m²;
Show all 10Show fewer
  • not to live above 800m of altitude;
  • to be vaccinated against COVID-19 and to have no symptoms (fever, cough, fatigue, loss of smell or taste);
  • able to complete all sessions;
  • able to give consent.

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • University of Lausanne

    Lausanne, Canton of Vaud, 1824

Other trials in Switzerland

About this study

Official title: Intermittent Hypoxic vs Blood Flow Restriction vs Eccentric Moderate-intensity Exercise in Elderly

Aging is linked to a higher risk of cardiovascular disease. Physical exercise is recognized as an excellent strategy to prevent cardiovascular diseases and cognitive aspects, generating healthier elderly people. The beneficial effects of physical training seem to be greater when performed:

  • In hypoxic conditions (i.e. when the amount of oxygen in the air is decreased as at altitude).
  • With intermittent blood flow restriction (by inflating pneumatic cuffs around the thighs to a pressure that restricts blood flow). This equipment is harmless.
  • With eccentric training (resisting against the movement of the pedal of a bicycle rather than pushing it).

The purpose of this study is then to evaluate whether moderate intensity intermittent training can induce similar or greater effects on cardiovascular health when combined with intermittent hypoxia, intermittent blood flow restriction or eccentric training.

Read the detailed description

Aging is associated with a higher risk of cardiovascular disease due mainly to high blood pressure. Physical exercise is recognized as an excellent non-pharmacological strategy to prevent cardiovascular disease and cognitive aspects, thus generating healthier elderly people.

  • Interestingly, living at altitude seems to reduce some cardiovascular risks. In addition, the beneficial effects of physical training seem to be greater when performed under hypoxic conditions (i.e. when the amount of oxygen in the air is decreased as at altitude).
  • Another interesting strategy for the elderly is intermittent blood flow restriction. This involves inflating pneumatic cuffs around the limb(s) to a pressure that blocks or restricts blood flow to the affected muscles, alternating with rest phases. It has been found that endurance training, combined with blood flow restriction, promotes the growth of new blood vessels, which could be particularly important for the prevention of cardiovascular disease in the elderly, which is unfortunately common.
  • Eccentric training is currently emerging as a promising training strategy for the elderly. It consists of resisting the movement of the pedal of a bicycle rather than pushing it. It requires less energy effort than traditional exercise with the same workload. Eccentric training has been shown to improve older adults' body composition and muscle strength, thereby improving exercise capacity and quality of life.

These training strategies may be of interest for cardiovascular health in older adults. However, there are few data on their combined effects with exercise in the elderly and there is no consensus to favor one method over another.

The objective of this study is then to evaluate whether moderate-intensity intermittent training can induce similar or superior effects on health indicators when combined with intermittent hypoxia, partial vascular occlusion, or eccentric training.

Conditions
Healthy Aging
Being tested
Exercise
Keywords
Hypoxia, Blood Flow Restriction, Eccentric cycling, Exercice, Elderly
Medical subject headings
Hypoxia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ExerciseBehavioural

    Participants will perform 3 times a week for 4 weeks a moderate intensity interval training.

Study groups in NCT05207501
Study groupRoleWhat they receive
Moderate-intensity intermittent training (MIIT)Active comparatorThe MIIT will be conducted on a cycle ergometer (Lode Ex. calibur Sport Ergometer, Lode B.V., the Netherlands) in normoxia (FiO2 = ~ 21%). The participants will perform the MIIT starting with the ergometer resistance set to obtain the %HRmax set (~75-80%) during 5 minutes and will rest 5 minutes after each interval of exercise. The HRmax will be considered as 200 - age.
Receives: Behavioral: Exercise
MIIT during intermittent hypoxic exposure (IHYP + MIIT)ExperimentalA normobaric hypoxic chamber (ATS Altitude Training, Sydney, Australia) will be used for this protocol. The chamber (2.4 m x 5 m x 2.5 m) allows, via a filter and compressor system, to extract oxygen molecules and to reduce the fraction of inspired oxygen (FiO2) with no modification of the barometric pressure.
Receives: Behavioral: Exercise
MIIT during intermittent blood flow restriction (IBFR + MIIT)ExperimentalThe IBFR + MIIT protocol will be performed while cycling in normoxia (FiO2 = ~ 21%). Elastic, pneumatic cuffs (BStrong, Park City, Utah, USA) will be administered as high as possible at the inguinal crease of the upper thigh and will be inflated during the cycling to the set pressure of 400 mmHg (except for the first training session, it will be of 250 mmHg to minimize soreness and to accustom patients to vascular occlusion training). The cuffs will be deflated at interval rest.
Receives: Behavioral: Exercise
Moderate-intensity eccentric cycling (MIEC)ExperimentalThe MIEC will be conducted on a cycle ergometer (Excalibur, Lode, Groningen, The Nederlands) in normoxia (FiO2 = ~ 21%). The participants will be instructed to resist against the pedal movement (cadence set at 15 revolutions/min) to produce the required torque (set to obtain the 75-80%HRmax) indicated by visual feedback for 5 minutes and will rest 5 minutes after each interval of exercise. The HRmax will be considered as 200 - age. The HR responses will be monitored (Polar Electro Oy, Kempele, Finland).
Receives: Behavioral: Exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Blood pressure [mmHg]

    a major risk factor, when too high, for cardiovascular diseases.

    Measured: 4 weeks

  2. Baroreflex sensitivity

    A measurement of the mechanism that regulates acute blood pressure changes linked to the development and progression of cardiovascular diseases

    Measured: 4 weeks

  3. Flow-mediated dilation

    RHI index: a measure for arterial endothelial function

    Measured: 4 weeks

  4. Heart rate variability

    An independent predictor of cardiovascular mortality and sudden cardiac death.

    Measured: 4 weeks

  5. 6-Minute Cycle Test [km]

    an estimation of the maximal aerobic capacity

    Measured: 4 weeks

  6. Knee flexion and extension isokinetic strength [N]

    The knee flexion and extension strength will be measured with an isokinetic dynamometer

    Measured: 4 weeks

  7. Muscle mass [kg]

    An analysis of muscle mass will be done using DXA scan

    Measured: 4 weeks

  8. Body fat [kg]

    An analysis of body fat will be done using DXA scan

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jan 2022
  2. Study start1 Sep 2022
  3. Primary completion30 Mar 2023
  4. Study completion30 Mar 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
This study is designed as a randomized parallel group active-control study.
Masking
Single blind
Who is masked
Participant
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05207501
Sponsor's protocol ID
2021-02135
Acronym
4MIIT
Status last verified
Apr 2023
First submitted
23 Dec 2021
Last updated
27 Apr 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Exercise in people with Healthy Aging, run by University of Lausanne at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Apr 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Blood pressure [mmHg] (time frame: 4 weeks). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Apr 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in